Trials / Completed
CompletedNCT00839293
Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules
Comparison of Fenofibric Acid Bioavailability From 45 mg and 135 mg Strength ABT-335 Capsules
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (estimated)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the safety and compare the bioavailability of fenofibric acid from 2 different dosage strengths of ABT-335.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ABT-335 | Once, see arm description for more information |
Timeline
- Start date
- 2009-02-01
- Primary completion
- 2009-03-01
- First posted
- 2009-02-09
- Last updated
- 2010-10-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00839293. Inclusion in this directory is not an endorsement.